BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 32859644)

  • 1. Association between acute respiratory failure requiring mechanical ventilation and the production of advanced glycation end products.
    Edriss H; Molehin AJ; Gavidia R; Selvan K; Nugent K
    J Investig Med; 2020 Oct; 68(7):1235-1240. PubMed ID: 32859644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycated Serum Albumin and AGE Receptors.
    Vetter SW
    Adv Clin Chem; 2015; 72():205-75. PubMed ID: 26471084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end products and glycosaminoglycans in patients with diabetic ketoacidosis.
    Edriss H; Molehin AJ; Selvan K; Gavidia R; Patel PU; Nugent K
    J Investig Med; 2020 Mar; 68(3):738-742. PubMed ID: 31672720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond the Alveolar Epithelium: Plasma Soluble Receptor for Advanced Glycation End Products Is Associated With Oxygenation Impairment, Mortality, and Extrapulmonary Organ Failure in Children With Acute Respiratory Distress Syndrome.
    Lim MJ; Zinter MS; Chen L; Wong KMY; Bhalla A; Gala K; Guglielmo M; Alkhouli M; Huard LL; Hanudel MR; Vangala S; Schwingshackl A; Matthay M; Sapru A
    Crit Care Med; 2022 May; 50(5):837-847. PubMed ID: 34678846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.
    Basta G; Sironi AM; Lazzerini G; Del Turco S; Buzzigoli E; Casolaro A; Natali A; Ferrannini E; Gastaldelli A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4628-34. PubMed ID: 16926247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin Oxidation and Albumin Glycation Discordance During Type 2 Diabetes Therapy: Biological and Clinical Implications.
    Vaishnav MS; Kumari N; Srikanta S; Simha V; Krishnaswamy PR; Balaram P; Bhat N
    Metab Syndr Relat Disord; 2024 Jun; 22(5):372-384. PubMed ID: 38696648
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
    Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
    Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concordance the hemoglobin glycation index with glycation gap using glycated albumin in patients with type 2 diabetes.
    Kim MK; Jeong JS; Kwon HS; Baek KH; Song KH
    J Diabetes Complications; 2017 Jul; 31(7):1127-1131. PubMed ID: 28487124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes.
    Yoshiuchi K; Matsuhisa M; Katakami N; Nakatani Y; Sakamoto K; Matsuoka T; Umayahara Y; Kosugi K; Kaneto H; Yamasaki Y; Hori M
    Endocr J; 2008 Jul; 55(3):503-7. PubMed ID: 18445997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products (AGEs) and their soluble receptors (sRAGE) as early predictors of reno-vascular complications in patients with uncontrolled type 2 diabetes mellitus.
    Farhan SS; Hussain SA
    Diabetes Metab Syndr; 2019; 13(4):2457-2461. PubMed ID: 31405660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unveiling the molecular mechanisms underpinning biorecognition of early-glycated human serum albumin and receptor for advanced glycation end products.
    Tramarin A; Naldi M; Degani G; Lupu L; Wiegand P; Mazzolari A; Altomare A; Aldini G; Popolo L; Vistoli G; Przybylski M; Bartolini M
    Anal Bioanal Chem; 2020 Jul; 412(18):4245-4259. PubMed ID: 32367292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between intraoperative ventilator settings and plasma levels of soluble receptor for advanced glycation end-products in patients without pre-existing lung injury.
    Jabaudon M; Futier E; Roszyk L; Sapin V; Pereira B; Constantin JM
    Respirology; 2015 Oct; 20(7):1131-8. PubMed ID: 26122046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis.
    Peacock TP; Shihabi ZK; Bleyer AJ; Dolbare EL; Byers JR; Knovich MA; Calles-Escandon J; Russell GB; Freedman BI
    Kidney Int; 2008 May; 73(9):1062-8. PubMed ID: 18288102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum advanced glycation end-products and receptors as prognostic biomarkers in diabetics undergoing coronary artery stent implantation.
    Shen Y; Pu LJ; Lu L; Zhang Q; Zhang RY; Shen WF
    Can J Cardiol; 2012; 28(6):737-43. PubMed ID: 23073352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous Detection of Serum Glucose and Glycated Albumin on a Paper-Based Sensor for Acute Hyperglycemia and Diabetes Mellitus.
    Ki H; Jang H; Oh J; Han GR; Lee H; Kim S; Kim MG
    Anal Chem; 2020 Sep; 92(17):11530-11534. PubMed ID: 32799523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum albumin-adjusted glycated albumin is a better indicator of glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    Ann Clin Biochem; 2015 Jul; 52(Pt 4):488-96. PubMed ID: 25568140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action of metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study.
    Adeshara KA; Bangar NS; Doshi PR; Diwan A; Tupe RS
    Diabetes Metab Syndr; 2020; 14(5):1449-1458. PubMed ID: 32769032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insights on glycated albumin].
    Hay-Lombardie A; Kamel S; Bigot-Corbel E
    Ann Biol Clin (Paris); 2019 Aug; 77(4):407-414. PubMed ID: 31418702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
    Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
    Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
    Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.